Trevi Therapeutics
TRVI----
Trevi Therapeutics (TRVI)
Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and commercializes investigational therapy for the treatment of chronic cough in...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Trevi Therapeutics Analyst Rating
View MoreForecast & Rating
Jul 21, 2026Price forecast
$26.1849.31%
Forecast & RatingStrong buy
11analysts
- Strong buy81.82%
- Buy18.18%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- benzinga_article · Jul 21 at 09:32 AM
Trevi Therapeutics shares are trading higher after BMO Capital initiated its coverage on the stock with an Outperform rating and announced a price target of $36.
- benzinga_article · Jul 21 at 06:58 AM
This Insmed Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
- benzinga_article · Jul 20 at 06:28 AM
This Urban Outfitters Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
- benzinga_article · Jul 14 at 07:05 AM
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- rttnews · Jun 20 at 05:19 AM
5 Biotech Stocks That Delivered Triple-Digit Gains - SYRE Up 400%, BFLY Up 300% & More
- PUBT · Jun 17 at 06:30 AM
Trevi Therapeutics management attends BIO International Convention in June and July events
